SIE

206

+0.56%↑

AIR.FR

160.44

+1.01%↑

ENR.DE

142.55

+1.31%↑

RHM

1,446.5

+2.44%↑

HO

253.1

+2.89%↑

SIE

206

+0.56%↑

AIR.FR

160.44

+1.01%↑

ENR.DE

142.55

+1.31%↑

RHM

1,446.5

+2.44%↑

HO

253.1

+2.89%↑

SIE

206

+0.56%↑

AIR.FR

160.44

+1.01%↑

ENR.DE

142.55

+1.31%↑

RHM

1,446.5

+2.44%↑

HO

253.1

+2.89%↑

SIE

206

+0.56%↑

AIR.FR

160.44

+1.01%↑

ENR.DE

142.55

+1.31%↑

RHM

1,446.5

+2.44%↑

HO

253.1

+2.89%↑

SIE

206

+0.56%↑

AIR.FR

160.44

+1.01%↑

ENR.DE

142.55

+1.31%↑

RHM

1,446.5

+2.44%↑

HO

253.1

+2.89%↑

Search

LISI.

Cerrado

SectorAcciones industriales

52.3 2.95

Resumen

Variación precio

24h

Actual

Mínimo

50.2

Máximo

52.5

Métricas clave

By Trading Economics

Ingresos

-14M

25M

Ventas

-240M

769M

P/B

Media del Sector

37.059

57.257

Rentabilidad por dividendo

0.93

Margen de beneficios

3.22

Empleados

9,537

EBITDA

-33M

106M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+21.33% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.93%

2.27%

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-539M

2.3B

Apertura anterior

49.35

Cierre anterior

52.3

Noticias sobre sentimiento de mercado

By Acuity

83%

17%

71 / 405 Clasificación en Industrials

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

LISI. Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

31 mar 2026, 23:31 UTC

Acciones populares

Stocks to Watch: Nike, RH, NCino

31 mar 2026, 22:35 UTC

Ganancias

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1 abr 2026, 00:00 UTC

Adquisiciones, fusiones, absorciones

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31 mar 2026, 23:50 UTC

Adquisiciones, fusiones, absorciones

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31 mar 2026, 23:43 UTC

Charlas de Mercado

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31 mar 2026, 23:33 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31 mar 2026, 23:21 UTC

Ganancias

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31 mar 2026, 23:14 UTC

Charlas de Mercado
Ganancias

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31 mar 2026, 23:12 UTC

Charlas de Mercado

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31 mar 2026, 22:36 UTC

Ganancias

China Vanke 2025 Loss Widens >000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31 mar 2026, 21:46 UTC

Adquisiciones, fusiones, absorciones

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31 mar 2026, 21:36 UTC

Charlas de Mercado

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31 mar 2026, 21:35 UTC

Ganancias

Nike Expects China Sales Down 20% in 4Q, CFO Says

31 mar 2026, 21:35 UTC

Ganancias

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31 mar 2026, 21:35 UTC

Ganancias

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31 mar 2026, 21:33 UTC

Adquisiciones, fusiones, absorciones

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31 mar 2026, 21:33 UTC

Ganancias

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31 mar 2026, 21:32 UTC

Ganancias

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31 mar 2026, 21:28 UTC

Ganancias

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31 mar 2026, 21:26 UTC

Ganancias

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31 mar 2026, 21:25 UTC

Ganancias

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31 mar 2026, 21:24 UTC

Charlas de Mercado
Ganancias

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31 mar 2026, 21:22 UTC

Ganancias

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31 mar 2026, 21:22 UTC

Ganancias

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31 mar 2026, 21:21 UTC

Ganancias

Nike's Digital Channel Still Too Promotional, CFO Says

31 mar 2026, 21:20 UTC

Ganancias

Nike CEO: Converse Remains Important to Portfolio

Comparación entre iguales

Cambio de precio

LISI. previsión

Precio Objetivo

By TipRanks

21.33% repunte

Estimación a 12 Meses

Media 62 EUR  21.33%

Máximo 62 EUR

Mínimo 62 EUR

De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para LISI. Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

1 ratings

1

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

27.7 / 28.3Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Weak Bullish Evidence

Largo Plazo

Strong Bullish Evidence

Sentimiento

By Acuity

71 / 405 Clasificación en Acciones industriales

Noticias sobre sentimiento de mercado

Coyuntura bajista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Finanzas

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de LISI.

Lisi S.A. provides assembly and component solutions for the aerospace, automotive, and medical sectors in France and internationally. It operates through three divisions: LISI Aerospace, LISI Automotive, and LISI Medical. The company offers aeronautic fastener solutions; structural components and parts for aircraft, helicopters, and airplanes; air conditioning and pressurization products, actuation and power components, helicopter rotors, landing gear structures, tanks and accumulators, and wheels and brakes; fan blades, outlet guide vanes, compressor blades, fixed vanes, variable vanes, disks, blisks, impellers, gears, inner and outer rings, and housings, as well as accessories and equipment, hot and cold section products for jet engines and turboshafts; and defense and space products. It also provides threaded fasteners, including screws, bolts, nuts, washers, special parts, etc. for industrial and automotive systems; clipped solutions, such as panel and trim fasteners, clipped nuts and screws, fasteners and connectors for cables and tubes, anti-creep rings, etc.; and braking systems, seating, occupant safety systems, fuel system components, etc. In addition, the company offers reconstruction implants and instruments, and spine and orthopedic implants; components and instruments for manual or robotic mini-invasive surgery; and components for laparoscopy, endoscopy, cardiovascular, neuro-cerebral surgery, etc. The company was formerly known as GFI Industries and changed its name to Lisi S.A. in 2002. The company was founded in 1777 and is headquartered in Belfort, France.
help-icon Live chat